Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This study will assess the safety and tolerability of oral single dose applications of AFQ056 in GERD patients.

Phase 1

Novartis